Latest Blogs

Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Subscribe to this column

International Perspectives

International Perspectives provides an interactive platform for international leaders in their respective fields to share perspectives on oncology topics. International Perspectives contributors are invited to post by invitation from ASCO’s volunteer leadership and key staff.

Feb 02, 2015
Owing to insufficient public and private investment in chronic disease prevention and control, millions of sub-Saharan Africans present with late stage, life-threatening diseases -- including cancer. Because of poor health systems and symptom control infrastructure, and limited numbers of...
Feb 02, 2015
By Monica Malik MD, DNB. It is estimated that almost 50% of all cancers are related to unhealthy choices like tobacco, alcohol, physical inactivity, unhealthy eating habits, unsafe sex and other modifiable environmental factors. Obesity is already on its way to overtake tobacco as the leading cause...
Feb 02, 2015
By Ian N. Olver, MD, PhD, FRACP. One-third of cancer deaths could be prevented by lifestyle choices alone. If there was a drug that claimed that success, it would be front page news. Changing behavior doesn’t seem dramatic, yet can be very difficult to achieve. The three areas in which the most...
Feb 02, 2015
By Sana Al Sukhun, MD, MSc, President of Jordan Oncology Society. Early detection has become the motto of public health campaigns all over the world. Not only does it reduce the burden of disease by reducing morbidity (complications of both disease and treatment), but also by reducing associated...
Feb 02, 2015
By Paul Ruff, MD, University of Witwatersrand, Johannesburg, South Africa. Since the turn of the century, we have seen a paradigm shift in the way we treat cancer, with the advent of targeted therapies, especially monoclonal antibodies and small molecule kinase inhibitors. Indeed the development of...
Nov 18, 2014
Tanja Cufer, MD, PhDASCO International Clinical Trials Workshop (ICTW) Working Group Chair    Dr. Tanja Cufer presents at the International Clinical Trials 

Pages